About the Sponsor
Metastatic breast cancer, or MBC, is life changing. Because of that, every one of you: individuals, caregivers, family members, and friends have important stories to tell. Visit lifebeyondpink.com for stories from across the MBC community and resources that we hope will help you along your experience
AstraZeneca is leading the charge to redefine how cancer is classified and treated to deliver even more effective treatments for patients across subtypes and stages. With a robust clinical trial program and an industry-leading portfolio, AstraZeneca’s ambition is to help contribute to the elimination of cancer as a cause of death.
AstraZeneca proudly partners with patient advocacy organizations devoted to optimizing the care of patients with breast, ovarian, and hereditary cancers by providing various patient education, navigation, health equity, and research efforts. Through these collaborations, AstraZeneca is committed to supporting patients at every step of the journey from diagnosis, to treatment and beyond by bringing new innovative medicines to patients, while partnering on programs that connect patients to essential resources for their care.
In addition to these partnerships, AstraZeneca has also launched three patient education platforms in metastatic breast cancer, BRCA mutation cancers, and HRD-positive ovarian cancer.
Resources
